A carregar...

ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway

BACKGROUND: Drug resistance is one of the major concerns in the treatment of hepatocellular carcinoma (HCC). The aim of the present study was to determine whether aberrant high expression of the inhibitor of differentiation 1(ID1) confers oxaliplatin-resistance to HCC by activating the pentose phosp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Exp Clin Cancer Res
Main Authors: Yin, Xin, Tang, Bei, Li, Jing-Huan, Wang, Yan, Zhang, Lan, Xie, Xiao-Ying, Zhang, Bo-Heng, Qiu, Shuang-Jian, Wu, Wei-Zhong, Ren, Zheng-Gang
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5701377/
https://ncbi.nlm.nih.gov/pubmed/29169374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-017-0637-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!